Why is Transgene Biotek falling/rising?

As of 02-Jul, Transgene Biotek Ltd's stock price is currently at 4.69, reflecting an increase of 0.1, or 2.18%. The stock has shown a strong performance today, outperforming its sector by 2.93%. Additionally, it has higher prices than its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. The stock has also seen a significant rise in investor participation, with delivery volume increasing by 40.45% compared to the 5-day average. However, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Transgene Biotek's short-term performance over the past week shows a return of +5.39%, which significantly outpaces the Sensex's return of +0.79% during the same period. Over the past month, the stock has increased by 12.74%, again outperforming the Sensex's 2.50% gain. Despite these positive short-term trends, the stock has a year-to-date decline of -31.33%, contrasting with the Sensex's increase of +6.75%, indicating that while the stock is currently experiencing a rise, it has faced considerable challenges over a longer timeframe.